By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
MabVax Therapeutics' Fully Human Antibody Approach To Cancer Therapeutics And Imaging Featured In Three Presentations At AACR Annual Meeting In New Orleans 4/18/2016 8:12:10 AM
MabVax Therapeutics Hires Paul Resnick, M.D. As Chief Business Officer 4/15/2016 6:17:10 AM
MabVax Therapeutics, Inc. Initiates Phase I Trial Of Humab-5B1 For Treatment Of Pancreatic Cancer 3/21/2016 6:18:28 AM
MabVax Therapeutics, Inc. To Present At The ROTH Conference 3/10/2016 8:02:21 AM
MabVax Therapeutics, Inc. To Present At BIO CEO & Investor Conference 2/3/2016 8:35:40 AM
MabVax Therapeutics, Inc. Receives FDA Authorization For Phase I Clinical Trial With 89Zr-Humab-5B1 As PET Imaging Agent For Pancreatic Cancer 2/1/2016 9:11:51 AM
MabVax Therapeutics, Inc. Executes A Debt Facility For Up To $10 Million 1/19/2016 6:48:51 AM
MabVax Therapeutics, Inc. Files IND For A Phase I Clinical Trial With 89Zr-Humab-5B1 1/6/2016 7:17:40 AM
MabVax Therapeutics, Inc. Announces FDA Authorization To Proceed With Humab-5B1 In A Phase I Clinical Trial For The Treatment For Pancreatic Cancer 1/4/2016 6:21:17 AM
MabVax Therapeutics, Inc. Files IND For Phase I Clinical Trial With Humab 5B1 As A Therapeutic For Pancreatic Cancer 12/1/2015 7:16:48 AM
12345
//-->